ROCKVILLE, Md., Feb. 19, 2019 /PRNewswire/ -- Synthetic
Biologics, Inc. (NYSE American: SYN), a late-stage clinical company
developing therapeutics designed to preserve the microbiome to
protect and restore the health of patients, intends to report
operational highlights and financial results for the year ended
December 31, 2018 on Wednesday, February 27, 2019, and will host a
conference call the same day at 4:30 p.m.
EST. The dial-in information for the call is as follows:
U.S. (toll free): 1-888-347-5280
International: +1 412-902-4280
Participants are asked to dial in 15 minutes before the start of
the call to register. The call will also be webcast over the
Internet at https://www.webcaster4.com/Webcast/Page/1096/29346. An
archived replay of the call will be available for approximately
ninety (90) days at the same URL,
https://www.webcaster4.com/Webcast/Page/1096/29346 beginning
approximately one hour after the call's conclusion.
About Synthetic Biologics, Inc.
Synthetic Biologics, Inc. (NYSE American: SYN) is a late-stage
clinical company developing therapeutics that preserve the
microbiome to protect and restore the health of patients. The
Company's lead late-stage candidates are: (1) SYN-004 (ribaxamase)
which is designed to protect the gut microbiome from the effects of
certain commonly used intravenous (IV) beta-lactam antibiotics to
prevent microbiome damage, C.
difficile infection (CDI), overgrowth of pathogenic
organisms and the emergence of antimicrobial resistance (AMR), and
(2) SYN-010 which is intended to reduce the impact of methane
producing organisms in the gut microbiome to treat an underlying
cause of irritable bowel syndrome with constipation (IBS-C). The
Company's preclinical pursuits include an oral formulation of the
enzyme intestinal alkaline phosphatase (IAP) to treat both local GI
and systemic diseases as well as monoclonal antibody therapies for
the prevention and treatment of pertussis. For more
information, please visit Synthetic Biologics' website at
www.syntheticbiologics.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/synthetic-biologics-to-report-2018-year-end-operational-highlights-and-financial-results-on-february-27-2019-300798056.html
SOURCE Synthetic Biologics, Inc.